Table: begin end state 1 11 non-cytoplasmic 12 31 transmembrane 32 58 cytoplasmic 59 83 transmembrane 84 88 non-cytoplasmic 89 109 transmembrane 110 137 cytoplasmic 138 157 transmembrane 158 174 non-cytoplasmic 175 194 transmembrane 195 202 cytoplasmic 203 224 transmembrane 225 233 non-cytoplasmic 234 256 transmembrane 257 293 cytoplasmic 294 315 transmembrane 316 338 non-cytoplasmic 339 360 transmembrane 361 376 cytoplasmic 377 393 transmembrane 394 398 non-cytoplasmic 399 422 transmembrane 423 483 cytoplasmic
Input: >Pf1N1B4_2024 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_2024 MLEVINDFLSGKVLIVLIVGLGSYFTIRSRFVQFRHFFHMFAVFRDSLRSSAGQLSSFQA LMLSLAGRVGAGNIAGVGIAVTLGGPGAVFWMWVTALVGMSSSFFECSLGQLYKRCDSEG QFRGGPSFYIQHGLQKRWLGMIMAFLLLITFGFAFNGLQAHAVTHSLNNAFGLDTTYTGL GLAVLLGLVFIGGIKRIAKVADLLVPVKTLVYIGVTIYVIVLQFDHVPGMLMTIVKSAFG LDQAFGGLIGSAIVMGVKRGVFANEAGLGSAPNVAAVASVEHPVSQGVVQAFSVFLDTFV ICTCTALLILLSGFYTPGFEGDGIALTQNSLAAVVGDWGRMFISVALALFVFTSILYNYY LGENNLRFMVGENRKALIGYRALVLVLIFWGAIENLGTVFAFADITMTMLAFVNLIALFL LFKVGMRILRDYDDQRAAGIKTPVFDSSKFPDLDLDLKAWPANPPAAAPTAAAEPQGVTA AQR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server